3rd International Mycobacterium ulcerans Conference (IMUC-III)

The WHO Collaborating Centre for Mycobacterium ulcerans in partnership with the Doherty Institute for Infection and Immunity will be hosting the 3rd International Mycobacterium ulcerans Conference (IMUC-III) from 20 – 22 November 2024 in Melbourne, Australia.

You can find more information about the the WHO Collaborating Centre for Mycobacterium ulcerans and the conference on the website here - https://www.doherty.edu.au/who-cc-m-ulcerans/imuc.

Buruli ulcer is a neglected tropical disease, caused by infection of subcutaneous tissue with the bacterium Mycobacterium ulcerans. The disease is often reported across several countries in West Africa, but Buruli ulcer case numbers have most recently been increasing in temperate south-eastern Australia. Despite substantial research progress to address key questions around how Buruli ulcer is transmitted, developing diagnostics and effective antibiotic treatments, there are still many challenges remaining.

With over 25 years since the last IMUC, the objectives of the IMUC-III conference are to:

• Reconnect and bring together international leading experts, medical professionals, early career researchers and students from across the globe working on (or interested in) M. ulcerans.
• Share experiences, learnings and research on how Buruli ulcer and the causative agent M. ulcerans is being studied, monitored, investigated and treated.
• Promote neglected skin diseases such as Buruli ulcer that impact lower-, middle- and high-income countries to varying degrees and highlight the importance of raising awareness of the severity and spread these diseases, and Buruli ulcer in particular.
• Showcase the progress made in addressing key issues of preventing and treating Buruli ulcer from public health and clinical perspectives.

Visit the IMUC-III website for further information and to register: https://go.unimelb.edu.au/3ke8

Please contact imuc-iii@unimelb.edu.au for any enquiries.